Mail Service Pharmacy (4.0) 4.0

OPS 5-1: Prescription Order Review

Submited by: Tom Goddard

The Basics

This standard requires your pharmacy to implement written P&Ps addressing:

  • Verification of the prescription source;
  • The legibility of the prescription (and if it is illegibility, activities to clarify the prescription);
  • A drug utilization mechanism that addresses the full array of DrUM considerations; 
  • Communication with the prescriber and patient, as appropriate, to resolve any discrepancies regarding either the medication or benefit/coverage; and
  • Thorough documentation of all communications with the prescriber.

Management Tips

Your P&P should provide your pharmacists with clear guidance on how to perform each of the required functions. 
Prescription source verification will differ from one pharmacy to the next, but in any event should be documented. If the pharmacy receives prescriptions only from providers within the same network as the pharmacy, an online check will suffice, so long as that check is documented. If the prescriber is known to the pharmacist, that, too, should be documented. 
URAC lists the key DrUM considerations as follows:

  • Therapeutic appropriateness
  • Over and underutilization
  • Generic use
  • Therapeutic interchange
  • Duplication
  • Drug-disease contraindications
  • Drug-drug and drug-allergy interactions
  • Drug dosage ix. Duration of treatment
  • Drug misuse
  • Drug-age precautions
  • Drug-gender precautions
  • Drug-pregnancy precautions
  • Regulatory limitations
A "discrepancy" in the prescription might be a number of things, such as wrong dosage or a dosage not written for the way the drug is manufactured (pill size or injectable vs. tablet).
We cannot stress this too much: each of three activities needs to have a place in your system for documentation of the action by the pharmacist.

Accreditation Tips

Desktop Review
Your P&P will suffice as documentation at the desktop review phase, but only so long as it addresses all of the above issues.
Onsite Review
The reviewer will interview and observe the pharmacist who oversees the prescription order review process.

  • Health Utilization Management 7.4 / 04.01.2020

    HUM 41 - Appeal Record Documentation

    This standard sets for the minimum requirements for your appeals records:Patient nameName of provider and/or facility rendering serviceCopies of all patient correspondenceCopies of all provider/facility correspondenceActions taken and the dates they were taken, including decisions, correspondence, and resolutionMinutes from any appeal proceedingsThe name and credentials of the appeals reviewer for...

  • Health Utilization Management 7.4 / 04.01.2020

    HUM 40 - Written Notice of Upheld Non-Certifications

    This standard prescribes the minimum requirements for the written notice of an adverse appeal decision (one upholding the initial denial of the request for certification):It must be sent to the patient and ordering provider or facilityIt must state the principal reasons for the decisionIt must state that your organization will provide the clinical rationale underlying decision in response to a wri...

  • Health Utilization Management 7.4 / 04.01.2020

    HUM 39 - Standard Appeal Process Time Frame

    This standard requires that, in the case of a standard appeal, you send written notification of the decision within 30 calendar days of the receipt of the request for appeal. That notice needs to go to both the patient and the ordering provider or treating facility.